|
JOSD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.100200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.371900E-04 |
| Normal-vs-Stage2 |
5.284000E-02 |
| Normal-vs-Stage3 |
5.679600E-02 |
| Normal-vs-Stage4 |
2.802300E-02 |
| Stage1-vs-Stage2 |
5.549200E-01 |
| Stage1-vs-Stage3 |
3.157600E-01 |
| Stage1-vs-Stage4 |
6.164400E-01 |
| Stage2-vs-Stage3 |
8.170000E-01 |
| Stage2-vs-Stage4 |
9.328200E-01 |
| Stage3-vs-Stage4 |
7.148600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.718240E-03 |
| Normal-vs-AfricanAmerican |
7.984600E-01 |
| Normal-vs-Asian |
8.672200E-02 |
| Caucasian-vs-AfricanAmerican |
5.770000E-02 |
| Caucasian-vs-Asian |
4.267600E-01 |
| AfricanAmerican-vs-Asian |
3.013800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.049960E-01 |
| Normal-vs-Female |
5.432900E-04 |
| Male-vs-Female |
1.288230E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.037800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.519660E-03 |
| Normal-vs-Age(61-80Yrs) |
7.142100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.224200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.545000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.182000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.131000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.270200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.564200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.870400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.046600E-01 |
| Classical-VS-Follicular |
1.540350E-02 |
| Classical-VS-Other |
6.822000E-02 |
| Classical-VS-Normal |
5.363300E-04 |
| Tall-VS-Follicular |
1.947690E-02 |
| Tall-VS-Other |
2.716500E-02 |
| Tall-VS-Normal |
1.221830E-03 |
| Follicular-VS-Other |
9.576800E-01 |
| Follicular-VS-Normal |
1.618980E-01 |
| Other-VS-Normal |
2.497600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.412410E-01 |
| Normal-vs-N1 |
3.400000E-02 |
| N0-vs-N1 |
3.490400E-01 |
|
|
